<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00841802</url>
  </required_header>
  <id_info>
    <org_study_id>STU00010040</org_study_id>
    <secondary_id>5R37HL068546</secondary_id>
    <nct_id>NCT00841802</nct_id>
  </id_info>
  <brief_title>Chronic Rhinosinusitis With or Without Nasal Polyps Steroid Study</brief_title>
  <official_title>Glucocorticosteroid Action in Inflammatory Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Northwestern University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Heart, Lung, and Blood Institute (NHLBI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Northwestern University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a study to evaluate the cause of chronic sinus disease. Oral steroids have long been
      used in the treatment of inflammatory conditions including chronic sinusitis, asthma, and
      arthritis. However, it is not well known exactly which patients will benefit from steroids
      when used in the treatment of chronic sinusitis. For some doctors, it is common practice to
      use these medications prior to planned sinus surgery, to lessen the inflammation and possibly
      help the healing process. Other doctors feel oral steroids may not be helpful in this way,
      and there is no conclusive data as to whether this practice has a long term benefit.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this research study is to better understand how this potential treatment
      option, oral steroids, affects biochemical substances that have been associated with the
      development of chronic sinusitis and polyps. In order to do this, we need to study people
      with different forms of chronic sinusitis and compare them to individuals without allergies
      or sinus disease. We will also look at patients with chronic sinusitis who are treated with
      oral steroids and compare them to chronic sinus patients who have not received oral steroid
      therapy prior to surgery. This study may help pave the way to new treatments that address
      specific parts of the chronic sinus inflammatory pathway.

      Hypotheses

        1. Oral steroid treatment of patients with CRS will lead to a correction in the
           inflammation that is observed in sinonasal tissues, nasal brushings, and nasal lavage.

        2. Steroid induced changes in inflammation will differ in chronic sinus patients with
           polyps than in those without polyps.

        3. Changes in inflammation will correlate with clinical variables.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>July 2008</start_date>
  <completion_date type="Anticipated">June 30, 2019</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2018</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Alterations of inflammatory cells, levels of key antibodies and cytokines, and expression of key epithelial genes</measure>
    <time_frame>Prior to surgery and steroid treatment and day of surgery w/ or w/o having been treated w/ steroids</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">50</enrollment>
  <condition>Chronic Sinusitis</condition>
  <condition>Rhinosinusitis</condition>
  <condition>Nasal Polyps</condition>
  <arm_group>
    <arm_group_label>Prednisone</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Steroid medication</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No Intervention</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>No Intervention</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Prednisone</intervention_name>
    <description>Prednisone 30mg once daily x 5 days</description>
    <arm_group_label>Prednisone</arm_group_label>
    <other_name>Glucocorticoid</other_name>
    <other_name>Deltasone</other_name>
    <other_name>Liquid Pred</other_name>
    <other_name>Meticorten</other_name>
    <other_name>Orasone</other_name>
    <other_name>Prednicen-M</other_name>
    <other_name>Prednicot</other_name>
    <other_name>Sterapred</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Ages 18 years to 70 years

          -  Diagnosis of chronic rhinosinusitis (CRS) with nasal polyps (NP) and will be
             undergoing sinonasal surgery for this condition

          -  Diagnosis of CRS without NP and will be undergoing sinonasal surgery for this
             condition

          -  No diagnosis of CRS and NP and will be undergoing nasal surgery
             (septoplasty/rhinoplasty, nasal fracture repair,etc.)

        Exclusion Criteria:

          -  Ages younger than 18 years and ages older than 70 years

          -  Diagnosis of an established immunodeficiency, pregnancy, coagulation disorder, a
             diagnosis of allergic fungal sinusitis (AFS), or cystic fibrosis

          -  Those with CRS with or without NP in whom systemic steroid therapy would be
             contraindicated

          -  Those who are dependent on systemic steroid therapy for sinonasal disease or any other
             condition
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Robert P Schleimer, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Northwestern University and Northwestern Memorial Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Northwestern University</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60611</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://www.nm.org/doctors/search-results?terms=schleimer#all-1</url>
    <description>Principal Investigator Site</description>
  </link>
  <reference>
    <citation>Van Zele T, Claeys S, Gevaert P, Van Maele G, Holtappels G, Van Cauwenberge P, Bachert C. Differentiation of chronic sinus diseases by measurement of inflammatory mediators. Allergy. 2006 Nov;61(11):1280-9.</citation>
    <PMID>17002703</PMID>
  </reference>
  <reference>
    <citation>Kanai N, Denburg J, Jordana M, Dolovich J. Nasal polyp inflammation. Effect of topical nasal steroid. Am J Respir Crit Care Med. 1994 Oct;150(4):1094-100.</citation>
    <PMID>7921442</PMID>
  </reference>
  <reference>
    <citation>Lavigne F, Cameron L, Renzi PM, Planet JF, Christodoulopoulos P, Lamkioued B, Hamid Q. Intrasinus administration of topical budesonide to allergic patients with chronic rhinosinusitis following surgery. Laryngoscope. 2002 May;112(5):858-64.</citation>
    <PMID>12150618</PMID>
  </reference>
  <reference>
    <citation>Wright ED, Agrawal S. Impact of perioperative systemic steroids on surgical outcomes in patients with chronic rhinosinusitis with polyposis: evaluation with the novel Perioperative Sinus Endoscopy (POSE) scoring system. Laryngoscope. 2007 Nov;117(11 Pt 2 Suppl 115):1-28.</citation>
    <PMID>18075447</PMID>
  </reference>
  <reference>
    <citation>Meltzer EO, Hamilos DL, Hadley JA, Lanza DC, Marple BF, Nicklas RA, Adinoff AD, Bachert C, Borish L, Chinchilli VM, Danzig MR, Ferguson BJ, Fokkens WJ, Jenkins SG, Lund VJ, Mafee MF, Naclerio RM, Pawankar R, Ponikau JU, Schubert MS, Slavin RG, Stewart MG, Togias A, Wald ER, Winther B; Rhinosinusitis Initiative. Rhinosinusitis: developing guidance for clinical trials. J Allergy Clin Immunol. 2006 Nov;118(5 Suppl):S17-61.</citation>
    <PMID>17084217</PMID>
  </reference>
  <reference>
    <citation>Richer SL, Truong-Tran AQ, Conley DB, Carter R, Vermylen D, Grammer LC, Peters AT, Chandra RK, Harris KE, Kern RC, Schleimer RP. Epithelial genes in chronic rhinosinusitis with and without nasal polyps. Am J Rhinol. 2008 May-Jun;22(3):228-34. doi: 10.2500/ajr.2008.22.3162.</citation>
    <PMID>18588753</PMID>
  </reference>
  <reference>
    <citation>Kato A, Peters A, Suh L, Carter R, Harris KE, Chandra R, Conley D, Grammer LC, Kern R, Schleimer RP. Evidence of a role for B cell-activating factor of the TNF family in the pathogenesis of chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol. 2008 Jun;121(6):1385-92, 1392.e1-2. doi: 10.1016/j.jaci.2008.03.002. Epub 2008 Apr 14.</citation>
    <PMID>18410958</PMID>
  </reference>
  <reference>
    <citation>Xu G, Mou Z, Jiang H, Cheng L, Shi J, Xu R, Oh Y, Li H. A possible role of CD4+CD25+ T cells as well as transcription factor Foxp3 in the dysregulation of allergic rhinitis. Laryngoscope. 2007 May;117(5):876-80.</citation>
    <PMID>17473687</PMID>
  </reference>
  <reference>
    <citation>Schleimer RP, Kato A, Kern R, Kuperman D, Avila PC. Epithelium: at the interface of innate and adaptive immune responses. J Allergy Clin Immunol. 2007 Dec;120(6):1279-84. Epub 2007 Oct 18. Review.</citation>
    <PMID>17949801</PMID>
  </reference>
  <reference>
    <citation>Kato A, Schleimer RP. Beyond inflammation: airway epithelial cells are at the interface of innate and adaptive immunity. Curr Opin Immunol. 2007 Dec;19(6):711-20. Epub 2007 Oct 24. Review.</citation>
    <PMID>17928212</PMID>
  </reference>
  <reference>
    <citation>Kato A, Favoreto S Jr, Avila PC, Schleimer RP. TLR3- and Th2 cytokine-dependent production of thymic stromal lymphopoietin in human airway epithelial cells. J Immunol. 2007 Jul 15;179(2):1080-7.</citation>
    <PMID>17617600</PMID>
  </reference>
  <reference>
    <citation>Schleimer RP, Lane AP, Kim J. Innate and acquired immunity and epithelial cell function in chronic rhinosinusitis. Clin Allergy Immunol. 2007;20:51-78. Review.</citation>
    <PMID>17534045</PMID>
  </reference>
  <reference>
    <citation>Kato A, Truong-Tran AQ, Scott AL, Matsumoto K, Schleimer RP. Airway epithelial cells produce B cell-activating factor of TNF family by an IFN-beta-dependent mechanism. J Immunol. 2006 Nov 15;177(10):7164-72.</citation>
    <PMID>17082634</PMID>
  </reference>
  <reference>
    <citation>Conley DB, Tripathi A, Seiberling KA, Schleimer RP, Suh LA, Harris K, Paniagua MC, Grammer LC, Kern RC. Superantigens and chronic rhinosinusitis: skewing of T-cell receptor V beta-distributions in polyp-derived CD4+ and CD8+ T cells. Am J Rhinol. 2006 Sep-Oct;20(5):534-9.</citation>
    <PMID>17063750</PMID>
  </reference>
  <reference>
    <citation>Lane AP, Truong-Tran QA, Schleimer RP. Altered expression of genes associated with innate immunity and inflammation in recalcitrant rhinosinusitis with polyps. Am J Rhinol. 2006 Mar-Apr;20(2):138-44.</citation>
    <PMID>16686375</PMID>
  </reference>
  <reference>
    <citation>Anand VK, Kacker A, Orjuela AF, Huang C, Manarey C, Xiang J. Inflammatory pathway gene expression in chronic rhinosinusitis. Am J Rhinol. 2006 Jul-Aug;20(4):471-6.</citation>
    <PMID>16955782</PMID>
  </reference>
  <reference>
    <citation>Schleimer RP. Glucocorticoids suppress inflammation but spare innate immune responses in airway epithelium. Proc Am Thorac Soc. 2004;1(3):222-30. Review.</citation>
    <PMID>16113438</PMID>
  </reference>
  <reference>
    <citation>Zhang N, Truong-Tran QA, Tancowny B, Harris KE, Schleimer RP. Glucocorticoids enhance or spare innate immunity: effects in airway epithelium are mediated by CCAAT/enhancer binding proteins. J Immunol. 2007 Jul 1;179(1):578-89.</citation>
    <PMID>17579079</PMID>
  </reference>
  <reference>
    <citation>Bolger WE, Joshi AS, Spear S, Nelson M, Govindaraj K. Gene expression analysis in sinonasal polyposis before and after oral corticosteroids: a preliminary investigation. Otolaryngol Head Neck Surg. 2007 Jul;137(1):27-33.</citation>
    <PMID>17599560</PMID>
  </reference>
  <verification_date>December 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 9, 2009</study_first_submitted>
  <study_first_submitted_qc>February 10, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 11, 2009</study_first_posted>
  <last_update_submitted>December 5, 2017</last_update_submitted>
  <last_update_submitted_qc>December 5, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">December 7, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Northwestern University</investigator_affiliation>
    <investigator_full_name>Robert Schleimer</investigator_full_name>
    <investigator_title>Professor of Medicine</investigator_title>
  </responsible_party>
  <keyword>Chronic sinusitis</keyword>
  <keyword>Chronic rhinosinusitis</keyword>
  <keyword>Nasal polyps</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Polyps</mesh_term>
    <mesh_term>Sinusitis</mesh_term>
    <mesh_term>Nasal Polyps</mesh_term>
    <mesh_term>Chronic Disease</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Prednisone</mesh_term>
    <mesh_term>Glucocorticoids</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

